These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18983494)

  • 1. Genetic variants and haplotypes of lipoprotein associated phospholipase A2 and their influence on cardiovascular disease (The Ludwigshafen Risk and Cardiovascular Health Study).
    Hoffmann MM; Winkler K; Renner W; Winkelmann BR; Seelhorst U; Wellnitz B; Boehm BO; März W
    J Thromb Haemost; 2009 Jan; 7(1):41-8. PubMed ID: 18983494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.
    Pokharel Y; Sun W; Polfus LM; Folsom AR; Heiss G; Sharrett AR; Boerwinkle E; Ballantyne CM; Hoogeveen RC
    Atherosclerosis; 2015 Aug; 241(2):641-8. PubMed ID: 26117401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen Risk and Cardiovascular Health Study).
    Kleber ME; Wolfert RL; De Moissl GD; Grammer TB; Dietz S; Winkelmann BR; Boehm BO; März W
    Clin Lab; 2011; 57(9-10):659-67. PubMed ID: 22029180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and lipoprotein-associated phospholipase A2 in smokers and nonsmokers of the Ludwigshafen Risk and Cardiovascular Health study.
    Kleber ME; Siekmeier R; Delgado G; Grammer TB; Winkelmann BR; Scharnagl H; Boehm BO; März W
    Adv Exp Med Biol; 2015; 832():15-23. PubMed ID: 25300684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
    Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
    Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between lipoprotein associated phospholipase A2 mass and subclinical coronary and carotid atherosclerosis in Retired National Football League players.
    Pokharel Y; Nambi V; Martin SS; Hoogeveen RC; Nasir K; Khera A; Wong ND; Jones PH; Boone J; Roberts AJ; Ballantyne CM; Virani SS
    Atherosclerosis; 2014 Oct; 236(2):251-6. PubMed ID: 25105582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Lipoprotein associated phospholipase A2 enzyme in medical undergraduate students with metabolic syndrome.
    Garg S; Malik P; Kar R; Sankar V; Mehndiratta M
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S21-4. PubMed ID: 26460076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible effects of lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms on cardiovascular risk in patients with preeclampsia.
    Güngör ZB; Tüten A; Ekmekçi H; Ekmekçi ÖB; Kucur M; Öncül M; Donma O; Madazlı R; Sönmez H
    J Matern Fetal Neonatal Med; 2018 Dec; 31(23):3119-3127. PubMed ID: 28784006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis.
    Winkler K; Hoffmann MM; Krane V; Drechsler C; Wanner C;
    Eur J Clin Invest; 2012 Jul; 42(7):693-701. PubMed ID: 22211481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Gestational Diabetes Mellitus increases placental and foetal lipoprotein-associated Phospholipase A2 which might exert protective functions against oxidative stress.
    Schliefsteiner C; Hirschmugl B; Kopp S; Curcic S; Bernhart EM; Marsche G; Lang U; Desoye G; Wadsack C
    Sci Rep; 2017 Oct; 7(1):12628. PubMed ID: 28974763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 single-nucleotide polymorphisms and cardiovascular events in patients with coronary artery disease.
    Maiolino G; Lenzini L; Pedon L; Cesari M; Seccia TM; Frigo AC; Rossitto G; Caroccia B; Rossi GP
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16(1):29-36. PubMed ID: 24732951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein-associated phospholipase A2 distribution among lipoproteins differs in type 1 diabetes.
    Jarvie JL; Wang H; Kinney GL; Snell-Bergeon J; Hokanson JE; Eckel RH
    J Clin Lipidol; 2016; 10(3):577-86. PubMed ID: 27206945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsynonymous polymorphisms in PLA2G7 gene are associated with the risk of coronary heart disease in a southern Chinese population.
    Hong M; Zhang M; Lu X
    Mamm Genome; 2015 Apr; 26(3-4):191-9. PubMed ID: 25690150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
    May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
    Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
    Campo S; Sardo MA; Trimarchi G; Bonaiuto A; Saitta C; Bitto A; Castaldo M; Cinquegrani M; Bonaiuto M; Cristadoro S; Saitta A
    Aging Clin Exp Res; 2008 Apr; 20(2):171-7. PubMed ID: 18431085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between lipoprotein-associated phospholipase A2 gene polymorphism and coronary artery disease in the Chinese Han population.
    Li L; Qi L; Lv N; Gao Q; Cheng Y; Wei Y; Ye J; Yan X; Dang A
    Ann Hum Genet; 2011 Sep; 75(5):605-11. PubMed ID: 21834908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.
    Casas JP; Ninio E; Panayiotou A; Palmen J; Cooper JA; Ricketts SL; Sofat R; Nicolaides AN; Corsetti JP; Fowkes FG; Tzoulaki I; Kumari M; Brunner EJ; Kivimaki M; Marmot MG; Hoffmann MM; Winkler K; März W; Ye S; Stirnadel HA; Boekholdt SM; Khaw KT; Humphries SE; Sandhu MS; Hingorani AD; Talmud PJ
    Circulation; 2010 Jun; 121(21):2284-93. PubMed ID: 20479152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.
    Katan M; Moon YP; Paik MC; Wolfert RL; Sacco RL; Elkind MS
    PLoS One; 2014; 9(1):e83393. PubMed ID: 24416164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive genetic analysis of the platelet activating factor acetylhydrolase (PLA2G7) gene and cardiovascular disease in case-control and family datasets.
    Sutton BS; Crosslin DR; Shah SH; Nelson SC; Bassil A; Hale AB; Haynes C; Goldschmidt-Clermont PJ; Vance JM; Seo D; Kraus WE; Gregory SG; Hauser ER
    Hum Mol Genet; 2008 May; 17(9):1318-28. PubMed ID: 18204052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal effect of Lipoprotein-associated phospholipase A2 activity on coronary artery disease and myocardial Infarction: A Two-Sample Mendelian Randomization study.
    Sun L; Zhu Z; Shi M; Jia Y; Yang P; Wang Y; Liu F; Zhang Y
    Clin Chim Acta; 2021 Dec; 523():491-496. PubMed ID: 34740601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.